跳至主要内容
临床试验/NCT05590234
NCT05590234已完成1 期

Dexmedetomidine Combined With Bupivacaine for Erector Spinae Plane Block Versus Bupivacaine Alone for Postoperative Pain Control of Posterior Lumbosacral Spine Fixation Surgeries

October 6 University1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2022年11月15日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
90
试验地点
1
主要终点
Postoperative visual analogue scale (VAS)

研究概览

简要总结

As the posterior lumbosacral spine fixation surgeries are common spine procedures done nowadays due to different causes and as this spine procedure is mostly accompanied with moderate to severe postoperative pain, so it is necessary to find an effective and efficient postoperative analgesia for patients with this surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • elective posterior lumbosacral spine fixation and fusion surgery due to different causes that diagnosed clinically and radiologically including MRI and Plain X ray

排除标准

  • hypersensitivity to the drugs used in the study [local anesthetics, non-steroidal anti-inflammatory drugs, opioids and the drug under investigation (dexmedetomidine)]
  • patients with any contraindication to regional anesthesia as skin infections at the site of the block
  • history of bleeding disorders or receiving anticoagulant medications

研究组 & 干预措施

control group (S group)

Placebo Comparator

patients received 20 ml of normal saline 0.9%.

干预措施: normal saline (Drug)

Dexmedetomidine combined with bupivacaine group (DB group)

Active Comparator

patients received 1ug/kg dexmedetomidine plus 20 mL of bupivacaine 0.25%,

干预措施: Dexmedetomidine injection (Drug)

Dexmedetomidine combined with bupivacaine group (DB group)

Active Comparator

patients received 1ug/kg dexmedetomidine plus 20 mL of bupivacaine 0.25%,

干预措施: Bupivacaine 0.25% Injectable Solution (Drug)

bupivacaine 0.25%,

Active Comparator

patients received 20 ml of bupivacaine 0.25%

干预措施: Bupivacaine 0.25% Injectable Solution (Drug)

结局指标

主要结局

Postoperative visual analogue scale (VAS)

时间窗: the first 24 hours postoperative

The visual analog scale (VAS) is a simple and often used method for evaluating variations in pain intensity.

Amount of post operative opioid consumption for the first 24 hours

时间窗: the first 24 hours postoperative

Amount of total opioid consumption for 24 hours postoperative

次要结局

  • Postoperative visual analogue scale (VAS)(the second 24 hour postoperative)
  • Amount of post operative opioid consumption for the second 24 hours(the second 24 hour postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

engy wahsh

lecturer of clinical pharmacy

October 6 University

研究点 (1)

Loading locations...

相似试验